Investments
8Portfolio Exits
3Funds
1About SBI JI Innovation Fund
SBI JI Innovation Fund is a biopharma focused venture capital firm. SBI JI Innovation Fund was formed as a partnership between SBI Holdings of Japan and Vertex.
SBI JI Innovation Fund Headquarter Location
Akerstein Towers B, 3rd Floor 11 HaMenofim St.
Herzliya,
Israel
+972-7-250-0610
Latest SBI JI Innovation Fund News
Mar 12, 2020
Biosight Ltd. , a Airport City, Israel-based pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, raised $19M in Series C financing. The round was led by Israel Biotech Fund (IBF) with participation from SBI JI Innovation Fund, Arkin Bio Ventures, and additional new and existing investors. The company intends to use the funds to advance the clinical development of its lead asset BST-236 (aspacytarabine), currently being investigated in a Phase 2b study as a single-agent, first-line treatment of acute myeloid leukemia (AML). Led by Dr. Ruth Ben Yakar, Chief Executive Officer, Biosight is a private clinical-stage biotech company, developing innovative therapeutics for hematological malignancies and disorders, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The BST-236 (aspacytarabine) is a novel proprietary anti-metabolite composed of cytarabine covalently bound to asparagine, acting as a pro-drug of cytarabine. BST-236 is designed to enable high-dose therapy with lower systemic exposure to free cytarabine and relative sparing of normal tissues. As such, BST-236 may serve as a superior therapy for AML and other hematological malignancies and disorders, including for older adults who are unfit for intensive therapy. BST-236 was granted Orphan Drug Designation from the FDA, which entitles Biosight to seven years of market exclusivity upon BST-236 marketing approval for the treatment of AML. FinSMEs
SBI JI Innovation Fund Investments
8 Investments
SBI JI Innovation Fund has made 8 investments. Their latest investment was in BioSight as part of their Series C on March 3, 2020.
SBI JI Innovation Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
3/11/2020 | Series C | BioSight | $19M | Yes | 4 | |
10/2/2019 | Series B | |||||
5/28/2019 | Series B | |||||
2/20/2019 | Series B | |||||
1/8/2019 | Series B |
Date | 3/11/2020 | 10/2/2019 | 5/28/2019 | 2/20/2019 | 1/8/2019 |
---|---|---|---|---|---|
Round | Series C | Series B | Series B | Series B | Series B |
Company | BioSight | ||||
Amount | $19M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 4 |
SBI JI Innovation Fund Portfolio Exits
3 Portfolio Exits
SBI JI Innovation Fund has 3 portfolio exits. Their latest portfolio exit was Ayala Pharmaceuticals on May 08, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/8/2020 | IPO | Public | 5 | ||
Date | 5/8/2020 | ||
---|---|---|---|
Exit | IPO | ||
Companies | |||
Valuation | |||
Acquirer | Public | ||
Sources | 5 |
SBI JI Innovation Fund Fund History
1 Fund History
SBI JI Innovation Fund has 1 fund, including SBI JI Innovation Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
SBI JI Innovation Fund | Multi-Stage Venture Capital | Open | 1 |
Closing Date | |
---|---|
Fund | SBI JI Innovation Fund |
Fund Type | Multi-Stage Venture Capital |
Status | Open |
Amount | |
Sources | 1 |
SBI JI Innovation Fund Team
3 Team Members
SBI JI Innovation Fund has 3 team members, including current Chief Executive Officer, Larry Montgomery.
Name | Work History | Title | Status |
---|---|---|---|
Larry Montgomery | Chief Executive Officer | Current | |
David Ben Ami | General Partner | Current | |
David Heller | General Partner | Current |
Name | Larry Montgomery | David Ben Ami | David Heller |
---|---|---|---|
Work History | |||
Title | Chief Executive Officer | General Partner | General Partner |
Status | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.